viewTHC Global Group Ltd

The Hydroponics Company is 'the gorilla in the room that people didn’t see coming'

The Hydroponics Company (ASX:THC) chief executive Ken Charteris explains to Proactive Investors the company’s international, vertically-integrated operations in both the hydroponics and medical cannabis sectors.

The company has made rapid advancements into the medical cannabis space, thanks in large part to numerous strategic alliances with significant global operators, and key acquisitions. Charteris explains, “now we have a medical cannabis company with the largest manufacturing plant in the southern hemisphere, thanks to a recent acquisition from a major pharmaceutical company. We have a fully-licensed growing facility in Bundaberg. We just recently [gained] the rights to another growing facility in northern New South Wales. As everybody understands, the sector in Australia is still in its development stages for patient applications, however the opportunity to export… brings a great amount of opportunity for this company.”

As of July 23rd, the first product will be available to doctors to prescribe under Special Access Scheme in Australia. With the licensing process on the manufacturing plant in the final stages now, the company is looking to commence exports of pharmaceutical-grade cannabis by Q1 next year. Charteris says, “we’re sort of like the gorilla in the room that people didn’t see coming… the asset base and team have been built to support that.”

“We actually are now really a truly international medical cannabis company, but we should not forget our roots as a hydroponics company out of Canada, which we are building out with more alliances which we will be reporting shortly,” teases Charteris.

Quick facts: THC Global Group Ltd

Price: 0.25 AUD

Market: ASX
Market Cap: $44.61 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...


Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

on 28/1/20

2 min read